Concepedia

Publication | Open Access

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis

253

Citations

29

References

2021

Year

References

YearCitations

Page 1